Clinical Trial Update: To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a fixed-dose combination of allisartan isoproxil and amlodipine in patients with essential hypertension not adequately controlled on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Allisartan Isoproxil (allisartan isoproxil)
• Amlodipine (amlodipine)

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED